Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(R)-2-(formyloxy)-3-(phosphonooxy)propyl pentanoate
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(R)-2-(formyloxy)-3-(phosphonooxy)propyl pentanoate is a synthetic small molecule belonging to the class of 1,2-diacylglycerol-3-phosphate derivatives. Its structure features a glycerol backbone substituted with a formyloxy group at the 2-position and a phosphonooxy group at the 3-position, with a pentanoic acid ester moiety. The compound is primarily of interest as an experimental chemical entity and has not been approved for any therapeutic use or clinical indication. There are no known clinical trials or marketed products containing this compound[1][2][4]. No mechanism of action or biological target has been established in public sources.
- Other names
- (2R)-2-(formyloxy)-3-(phosphonooxy)propyl valeratePentanoic acid, (2R)-2-(formyloxy)-3-(phosphonooxy)propyl esterValérate de (2R)-2-(formyloxy)-3-(phosphonooxy)propyle[(2R)-2-(formyloxy)-3-(pentanoyloxy)propoxy]phosphonic acid
Beyond the preview
Go deeper on (R)-2-(formyloxy)-3-(phosphonooxy)propyl pentanoate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (R)-2-(formyloxy)-3-(phosphonooxy)propyl pentanoate.